Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000899321 | SCV001043580 | benign | not provided | 2024-01-18 | criteria provided, single submitter | clinical testing | |
DBGen Ocular Genomics | RCV001593127 | SCV001816005 | benign | Retinitis pigmentosa | 2021-05-31 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003141892 | SCV003824970 | uncertain significance | Microcornea-myopic chorioretinal atrophy | 2019-03-29 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000899321 | SCV005255152 | benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV000899321 | SCV001918173 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000899321 | SCV001964507 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003910717 | SCV004734843 | likely benign | ADAMTS18-related disorder | 2022-08-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |